Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
To sustain these levels and prevent energy dips, we typically recommend a monthly injection protocol
BPC-157 is a peptide composed of 15 amino acids, originally discovered in a naturally occurring protective protein found in the stomach
Research published in the New England Journal of Medicine demonstrated that patients taking tirzepatide had significant reductions in A1c levels over 40 weeks (Jastreboff et al., 2022)
What payers require for Zepbound prior authorization Zepbound PA requirements are typically more stringent: Documented BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity Evidence of lifestyle intervention including documented participation in diet, exercise, and behavioral modification programs (usually for at least 3 to 6 months) Prior medication trials (some plans require documented failure of other weight management medications before approving tirzepatide) Specialist involvement (some plans require referral to or management by a bariatric medicine specialist, endocrinologist, or obesity medicine physician) Ongoing weight monitoring documentation with specific weight loss targets (typically 5% of baseline weight within 3 to 6 months of starting therapy) Patients researching BMI requirements for GLP-1 medications should understand that these thresholds directly correspond to the prior authorization criteria their provider must document
US$ 22.65
US$ 22.93
US$ 21.88
US$ 25.26
US$ 28.43
US$ 23.95
US$ 28.00
US$ 28.30
US$ 26.46
US$ 28.96
